Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 2952-2959

  Esposito, John G ^a   Thomas, Scott G ^a   Kingdon, Lori ^c   Ezzat, Shereen ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN GROWTH HORMONE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; CANADA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; IMPEDANCE; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKINFOLD THICKNESS; SPECTROSCOPY; WASTING SYNDROME; WEIGHT REDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33747743048     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0431     Document Type: Article

References (40)

1. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ 1995 Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 8:239-246
2. Thiebaut R, Malvy D, Marimoutou C, Davis F 2000 Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA). Eur J Epidemiol 16:633-639
3. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, Bartsch GE 1998 Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18:80-85
4. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860
5. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL 2002 Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31:230-236
6. Wanke CA, Silva M, Knox TA, Forrester J, Speigelman D, Gorbach SL 2000 Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 31:803-805
7. Esposito JG, Thomas SG, Kingdon L, Ezzat S 2005 Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting. Am J Physiol Endocrinol Metab 289:E494-E503
8. Jager H, Knechten H, Moll A, Weitner L, Fischer H, Schmitt-Rau K 2002 Treatment of HIV-associated wasting with recombinant human growth hormone: monitoring of body composition changes by bioelectrical impedance analysis (BIA). Eur J Med Res 7:103-108
9. Klauke S, Fischer H, Rieger A, Fruhauf L, Staszewski S, Althoff PH, Helm EB 2005 Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting. Int J STD AIDS 16:307-313
10. Batterham MJ, Garsia R, Greenop P 1999 Measurement of body composition in people with HIV/AIDS: a comparison of bioelectrical impedance and skinfold anthropometry with dual-energy x-ray absorptiometry. J Am Diet Assoc 99:1109-1111
11. Corcoran C, Anderson EJ, Burrows B, Stanley T, Walsh M, Poulos AM, Grinspoon S 2000 Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting. Am J Clin Nutr 72:1053-1058
12. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB 1996 Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 125:873-882
13. Cornish BH, Ward LC, Thomas BJ, Jebb SA, Elia M 1996 Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans. Eur J Clin Nutr 50:159-164
14. Cornish BH, Ward LC 1998 Data analysis in multiple-frequency bioelectrical impedance analysis. Physiol Meas 19:275-283
15. 1998 The Canadian physical activity, fitness, lifestyle appraisal: CSEP's plan for healthy active living. 2nd ed. Ottawa: Health Canada
16. Durnin JV, Womersley J 1974 Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97
17. Siri WE 1956 The gross composition of the body. Adv Biol Med Phys 4:239-280
18. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA 1986 Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327-1332
19. De Lorenzo A, Andreoli A, Matthie J, Withers P 1997 Predicting body cell mass with bioimpedance by using theoretical methods: a technological review. J Appl Physiol 82:1542-1558
20. Pace N, Rathbun EN 1945 Studies on body composition. III. The body water and chemically combined nitrogen content in relation to fat content. J Biol Chem 158:685-691
21. Grizzle JE 1965 The two-period change-over design and its use in clinical trials. Biometrics 21:467-480
22. Bland JM, Altman DG 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310
23. Aloia JF, Vaswani A, Ma R, Flaster E 1995 Comparative study of body composition by dual-energy x-ray absorptiometry. J Nucl Med 36:1392-1397
24. Haarbo J, Gotfredsen A, Hassager C, Christiansen C 1991 Validation of body composition by dual energy x-ray absorptiometry (DEXA). Clin Physiol 11:331-341
25. Heymsfield SB, Wang J, Heshka S, Kehayias JJ, Pierson RN 1989 Dual-photon absorptiometry: comparison of bone mineral and soft tissue mass measurements in vivo with established methods. Am J Clin Nutr 49:1283-1289
26. Prior BM, Cureton KJ, Modlesky CM, Evans EM, Sloniger MA, Saunders M, Lewis RD 1997 In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol 83:623-630
27. Ellis KJ, Bell SJ, Chertow GM, Chumlea WC, Knox TA, Kotler DP, Lukaski HC, Schoeller DA 1999 Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference. Nutrition 15:874-880
28. Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ 1999 Single- and multifrequency models for bioelectrical impedance analysis of body water compartments. J Appl Physiol 87:1087-1096
29. Kotler DP, Tierney AR, Wang J, Pierson Jr RN 1989 Magnitude of body cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447
30. Burgess E, Wanke C 2005 Use of recombinant human growth hormone in HIV-associated lipodystrophy. Curr Opin Infect Dis 18:17-24
31. Kamimura MA, Avesani CM, Cendoroglo M, Canziani ME, Draibe SA, Cuppari L 2003 Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy x-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant 18:101-105
32. Woodrow G, Oldroyd B, Smith MA, Turney JH 1996 Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy x-ray absorptiometry. Eur J Clin Nutr 50:295-301
33. Paton NI, Macallan DC, Jebb SA, Noble C, Baldwin C, Pazianas M, Griffin GE 1997 Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 14:119-127
34. Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG, Mathews M, Barron JR, Fitzpatrick DG, Gulliver W, Zhang H 2005 Comparison of multifrequency bioelectrical impedance analysis with dual-energy x-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr 81:74-78
35. Schwenk A, Breuer P, Kremer G, Ward L 2001 Clinical assessment of HIV-associated lipodystrophy syndrome: bioelectrical impedance analysis, anthropometry and clinical scores. Clin Nutr 20:243-249
36. Van Loan MD, Strawford A, Jacob M, Hellerstein M 1999 Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy. Aids 13:241-248
37. Engelson ES, Glesby MJ, Mendez D, Albu JB, Wang J, Heymsfield SB, Kotler DP 2002 Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection. J Acquir Immune Defic Syndr 30:379-391
38. Torres RA, Unger KW, Cadman JA, Kassous JY 1999 Recombinant human growth hormone improves truncal adiposity and 'buffalo humps' in HIV-positive patients on HAART. Aids 13:2479-2481
39. Wanke C, Gerrior J, Kantaros J, Coakley E, Albrecht M 1999 Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. Aids 13:2099-2103
40. Paton NI, Elia M, Jennings G, Ward LC, Griffin GE 1998 Bioelectrical impedance analysis in human immunodeficiency virus-infected patients: comparison of single frequency with multifrequency, spectroscopy, and other novel approaches. Nutrition 14:658-666